Lipopeptide vaccines - EQiTXAlternative Names: VacTX
Latest Information Update: 12 Nov 2009
At a glance
- Originator EQiTX
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Autoimmune disorders; Bacterial infections; Cancer; Hypersensitivity; Prostate cancer; Viral infections
Most Recent Events
- 21 Mar 2006 Phase-I clinical trials in Viral infections in Australia (unspecified route)
- 03 Aug 2005 Early research in Bacterial infections in Australia (unspecified route)
- 03 Aug 2005 Early research in Viral infections in Australia (unspecified route)